1887

Abstract

We have used salicylhydroxamic acid (SHAM) to inhibit intraphagosomal myeloperoxidase activity in order to evaluate the role of this enzyme in the killing of by human neutrophils. 50 -SHAM reduced the luminol-dependent chemiluminescence response stimulated during phagocytosis of unopsonized latex beads and opsonized by over 80% and 60%, respectively. When opsonized were incubated with neutrophils, 45% were killed within 15 min incubation and 60% by 1 h. However, in neutrophil suspensions incubated with 50 -SHAM, only 13% were killed by 15 min whilst 71% still remained viable after 1 h. This inhibitor had no effect upon the number of bacteria phagocytosed or upon degranulation. In a cell-free system, 25 -HO alone killed 55% of the bacteria, whereas in the presence of myeloperoxidase (i.e. 10 mU myeloperoxidase and 25 -HO) virtually all of the bacteria were killed: the addition of 50 -SHAM abolished this myeloperoxidase-enhanced killing but did not affect the HO-dependent killing. We therefore conclude that in normal neutrophils whilst HO is required for killing of this pathogen, both myeloperoxidase-dependent and -independent pathways exist.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-135-5-1187
1989-05-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/micro/135/5/mic-135-5-1187.html?itemId=/content/journal/micro/10.1099/00221287-135-5-1187&mimeType=html&fmt=ahah

References

  1. Babior B.M. 1978; Oxygen-dependent killing by phagocytes. New England Journal of Medicine 298:659–668
    [Google Scholar]
  2. Babior B.M. 1984; The respiratory burst of phagocytes. Journal of Clinical Investigation 73:599–601
    [Google Scholar]
  3. Breton-Gorius J., Houssay D., Dreyfus B. 1975; Partial myeloperoxidase deficiency in a case of preleukaemia. 1. Studies of fine structure and peroxidase synthesis of promyelocytes. British Journal of Haematology 30:273–278
    [Google Scholar]
  4. Cuperus R.A., Muijsers A.O., Wever R. 1986; The superoxide dismutase activity of myeloperoxidase: formation of compound III. Biochimica et biophysica acta 871:78–84
    [Google Scholar]
  5. Davies B., Edwards S.W. 1989; Inhibition of myeloperoxidase by salicylhydroxamic acid. Biochemical Journal 258:801–806
    [Google Scholar]
  6. Edwards S.W., Lloyd D. 1987; CO-reacting haemoproteins of neutrophils: evidence for cytochrome b-245 and myeloperoxidase as potential oxidases during the respiratory burst. Bioscience Reports 7:193–199
    [Google Scholar]
  7. Edwards S.W., Swan T.F. 1986; Regulation of superoxide generation by myeloperoxidase during the respiratory burst of human neutrophils. Bio-chemical Journal 237:601–604
    [Google Scholar]
  8. Edwards S.W., Say J.E., Hart C.A. 1987; Oxygen-dependent killing of Staphylococcus aureus by human neutrophils. Journal of General Microbiology 133:3591–3597
    [Google Scholar]
  9. Edwards S.W., Say J.E., Hughes V. 1988a; Gamma interferon enhances the killing of Staphylococcus aureus by human neutrophils. Journal of General Microbiology 134:37–42
    [Google Scholar]
  10. Edwards S.W., Hart C.A., Davies J.M., Pattison J., Hughes V., Sills J.A. 1988b; Impaired neutrophil killing in a patient with defective degranulation of myeloperoxidase. Journal of Clinical and Laboratory Immunology 25:201–206
    [Google Scholar]
  11. Elsbach P., Weiss J. 1983; A reevaluation of the role of the O2-dependent and O2-independent microbial systems of phagocytes. Reviews of Infectious Diseases 5:843–853
    [Google Scholar]
  12. Ganz T., Selsted M.E., Szklarek D., Harwig S.S.L., Daher K., Bainton D.F., Lehrer R.I. 1985; Defensins: natural peptide antibiotics of human neutrophils. Journal of Clinical Investigation 76:1427–1435
    [Google Scholar]
  13. Halliwell B., Gutteridge J.M.C. 1985 Free Radicals in Biology and Medicine. Oxford:: Clarendon Press.;
    [Google Scholar]
  14. Harrison J.E., Schultz J. 1976; Studies on the chlorinating activity of myeloperoxidase. Journal of Biological Chemistry 251:1371–1374
    [Google Scholar]
  15. Kitahara M., Eyre H.J., Simonian Y., Atkin C.L., Hasstedt S.J. 1981; Hereditary myeloper-oxidase deficiency. Blood 57:888–893
    [Google Scholar]
  16. Klebanoff S.J. 1968; Myeloperoxidase-halide-hydrogen peroxide antibacterial system. Journal of Bacteriology 95:2131–2138
    [Google Scholar]
  17. Klebanoff S.J., Clark R.A. 1978 The Neutrophil: Function and Clinical Disorders. Amsterdam:: North-Holland.;
    [Google Scholar]
  18. Klebanoff S.J., Pincus S.H. 1971; Hydrogen peroxide utilization in myeloperoxidase-deficient leukocytes: a possible microbicidal control mechanism. Journal of Clinical Investigation 50:2226–2229
    [Google Scholar]
  19. Lanza F., Fietta A., Spisani S., Castoldi G.L., Traniello S. 1987; Does a relationship exist between neutrophil myeloperoxidase deficiency and the occurrence of neoplasms?. Journal of Clinical and Laboratory Immunology 22:175–180
    [Google Scholar]
  20. Lehrer R.I., Cline M.J. 1969; Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infections. Journal of Clinical Investigation 48:1478–1488
    [Google Scholar]
  21. Murao S.I., Stevens S.J., Ito A., Huberman E. 1988; Myeloperoxidase: a myeloid cell nuclear antigen with DNA binding properties. Proceedings of the National Academy of Sciences of the United States of America 85:1232–1236
    [Google Scholar]
  22. Nauseef W.M. 1988; Myeloperoxidase deficiency. In Phagocytic Defects I: Abnormalities Outside of the Respiratory Burst pp. 135–158 Cumutte J.T. Edited by Philadelphia:: W.B.Saunders;
    [Google Scholar]
  23. Parry M.F., Root R.K., Metcalf J.A., Delaney K.K., Kaplow L.S., Richar W.J. 1981; Myeloperoxidase deficiency. Prevalence and clinical significance. Annals of Internal Medicine 95:293–301
    [Google Scholar]
  24. Pember S.O., Shapira R., Kinkade J.M. Jr 1983; Multiple forms of myeloperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity and sub-unit structure. Archives of Biochemistry and Biophysics 221:391–403
    [Google Scholar]
  25. Pui C.-H., Behm F.G., Kalwinsky D.K., Murphy S.B., Butler D.L., Dahl G.V., Mirro J. 1987; Clinical significance of low levels of myelo-peroxidase positivity in childhood acute nonlym-phoblastic leukemia. Blood 70:51–54
    [Google Scholar]
  26. Rich P.R., Wiegand N.K., Blum H., Moore A.L., Bonner W.D. Jr 1978; Studies on the mechanism of inhibition of redox enzymes by substituted hydroxamic acids. Biochimica et biophysica acta 525:325–337
    [Google Scholar]
  27. Rossi F. 1986; The O2 forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochimica et biophysica acta 853:65–89
    [Google Scholar]
  28. Salmon S.E., Cline M.J., Schultz J., Lehrer R.I. 1970; Myeloperoxidase deficiency. Immunological study of a genetic leukocyte defect. New England Journal of Medicine 282:250–253
    [Google Scholar]
  29. Schonbaum G.R., Bonner W.D. Jr Storey B.T., Bahr J.T. 1971; Specific inhibition of the cyanide-insensitive respiratory pathway in plant mitochondria by hydroxamic acids. Plant Physiology 47:124–128
    [Google Scholar]
  30. Spitznagel J.K. 1984; Nonoxidative antimicrobial systems in leucocytes. In Regulation of Leukocyte Function (Contemporary Topics in Immunology 14 pp. 234–283 Snyderman R. Edited by New York: Plenum;
    [Google Scholar]
  31. Tauber A.I., Borregaard N., Simons E., Wright J. 1983; Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies. Medicine 62:286–309
    [Google Scholar]
  32. Turner M.W., Grant C., Seymour N.D., Harvey B., Levinsky R.J. 1986; Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential. Immunology 58:111–115
    [Google Scholar]
  33. Winterbourne C.C., Garcia R.C., Segal A.W. 1985; Production of the superoxide adduct of myeloperoxidase (compound III) by stimulated human neutrophils and its reactivity with hydrogen peroxide and chloride. Biochemical Journal 228:583–592
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/00221287-135-5-1187
Loading
/content/journal/micro/10.1099/00221287-135-5-1187
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error